We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$172M
Cap. Flow
+$156M
Cap. Flow %
7.83%
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294

Sector Composition

Rank Sector Weight
1 Healthcare 2.95%
2 Consumer Discretionary 2.51%
3 Technology 1.96%
4 Energy 1.43%
5 Communication Services 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRP
601
DELISTED
Neurotrope, Inc. Common
NTRP
$105K 0.01%
+13,125
New +$88.3K
JWN
602
DELISTED
Nordstrom
JWN
$102K 0.01%
+3,200
New +$120K
OVV icon
603
PUT
Ovintiv
OVV
$17.3B
$102K 0.01%
+4,000
New +$125K
CCXI
604
DELISTED
ChemoCentryx, Inc.
CCXI
$102K 0.01%
+11,000
New +$127K
HOFT icon
605
Hooker Furnishings Corp
HOFT
$150M
$101K 0.01%
+4,901
New +$132K
NXST icon
606
CALL
Nexstar Media Group
NXST
$5.82B
$101K 0.01%
+1,000
New +$107K
SWBI icon
607
Smith & Wesson
SWBI
$651M
$101K 0.01%
+14,526
New +$103K
DVAX
608
PUT
DELISTED
Dynavax Technologies
DVAX
$100K 0.01%
25,000
-5,000
-17% -$29K
SLDB icon
609
Solid Biosciences
SLDB
$794M
$100K 0.01%
1,167
-1,400
-55% -$153K
TVTX icon
610
CALL
Travere Therapeutics
TVTX
$5.2B
$100K 0.01%
+5,000
New +$98.7K
BIG
611
DELISTED
Big Lots, Inc.
BIG
$97K ﹤0.01%
3,400
-5,100
-60% -$170K
CPRX
612
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
$96K ﹤0.01%
+25,000
New +$108K
BDSI
613
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$93K ﹤0.01%
20,000
-35,000
-64% -$163K
MHK icon
614
CALL
Mohawk Industries
MHK
$7.5B
$88K ﹤0.01%
600
CJ
615
DELISTED
C&J Energy Services, Inc.
CJ
$88K ﹤0.01%
7,500
BCRX icon
616
PUT
BioCryst Pharmaceuticals
BCRX
$2.28B
$76K ﹤0.01%
+20,000
New +$120K
OVV icon
617
Ovintiv
OVV
$17.3B
$76K ﹤0.01%
+3,000
New +$93.6K
AGEN
618
CALL
Agenus
AGEN
$312M
$75K ﹤0.01%
1,274
-2,043
-62% -$112K
AGEN
619
PUT
Agenus
AGEN
$312M
$75K ﹤0.01%
1,274
-2,043
-62% -$112K
EPZM
620
DELISTED
Epizyme, Inc
EPZM
$75K ﹤0.01%
+6,000
New +$77.2K
VRAY
621
DELISTED
ViewRay, Inc.
VRAY
$70K ﹤0.01%
8,000
-23,000
-74% -$187K
PAA icon
622
Plains All American Pipeline
PAA
$17.3B
$61K ﹤0.01%
2,500
-7,100
-74% -$169K
CURO
623
DELISTED
CURO Group Holdings Corp.
CURO
$60K ﹤0.01%
+5,500
New +$58.7K
VICI icon
624
VICI Properties
VICI
$29B
$57K ﹤0.01%
+2,600
New +$58.1K
BBW icon
625
Build-A-Bear
BBW
$425M
$56K ﹤0.01%
10,100
-34,900
-78% -$193K

Similar funds

Caption Management's Q2 2019 Portfolio in Review

As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.

By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.

  • Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
  • Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
  • Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
  • Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
  • Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
  • Caption Management opened 395 new positions and closed 294 in Q2 2019.
  • Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.

Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.